Tenet Diagnostics Announces Appointments: Preeminent Scientist as Laboratory Director, and Pain and Opioid Prescribing Expert as Director of Provider Relations

KENILWORTH, N.J. – November, 2017 –  Tenet Diagnostics (Tenet), providers of high-quality laboratory and genomic testing and evidence-based research designed to direct patient care for clinicians, employers and payers, announces today its appointment of Eric W. Johnson, Ph.D., as director of Laboratory Services, and Ashley Kiley, MPH, chair, Industry Advisory Committee and board member, New York Pain Society, as

Read More

Tenet Diagnostics Supports President Trump’s Declaration: Opioid Crisis is a Public Health Emergency

Calls for expanded physician prescribing education –(BUSINESS WIRE)–President Trump’s designation of the opioid crisis as a public health emergency takes an important step toward solving a problem that impacts people of all ages and ethnic groups throughout the nation. But more is needed to expand physician prescribing education. WHO: Scott Howell, M.D., MPH &TM, CPE, Chief Medical

Read More

Tenet Diagnostics Recommends Genomic Testing to Assess Cancer Risks: Employers & Payers Optimize Clinical Outcomes, Improve Member Satisfaction

KENILWORTH, N.J.–(BUSINESS WIRE)–Tenet Diagnostics (Tenet), providers of high-quality laboratory and genomic testing, and evidence-based research designed to direct patient care for clinicians, employers and payers, urges leaders to consider the benefits of offering genomic testing to identify abnormalities that dictate how a patient’s cancer behaves and determine how it can be proactively targeted with certain drug therapies. Collaborating with providers, Tenet reviews a member’s medical history, assesses the appropriate use of genetic and genomic testing,

Read More